mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.092 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |